earch support, and/or has coordinated education meetings for Abbott, AbbVie, Allergan, Bayer, Celgene, Ferring, Gilead, Janssen, MSD, Pfizer, Shire, and Takeda. All money has been received by her employer to support investigator-initiated research. CS has served as a key advisor to the development of the Ulcerative Colitis Treatment Options program in the United States by Emmi Solutions, Inc; has served as a consultant and is on the advisory boards for AbbVie, Amgen, Celgene, Janssen, Lilly, Pfizer, Prometheus, Salix, Sandoz, Sebela, and Takeda; has received speaker fees from AbbVie, Janssen, Pfizer, and Takeda; has received grant support from AbbVie, Janssen, Pfizer, Takeda, Broad Medical Research Program, Crohn's and Colitis Foundation of America (CCFA), and AHRQ (1R01HS021747-01); and is the co-chair of the CCFA quality of care program. SC is on advisory boards; has received speaker fees, educational support, and research support; and/or has coordinated education meetings for AbbVie, Celgene, Ferring, Gilead, Janssen, MSD, Orphan/Aspen, Pfizer, and Takeda.

Reviewers\' report - 2015 GESA AbbVie IBD Clinical Research Grant.

5-ASA

:   5-aminosalicylates

AQoL-8D

:   Assessment of Quality of Life-8D

CD

:   Crohn disease

CRCT

:   cluster randomized controlled trial

DA

:   decision aid

DCS

:   Decisional Conflict Scale

FC

:   fecal calprotectin

HADS-A

:   Hospital Anxiety and Depression Scale-Anxiety

heiQ

:   Health Education Impact Questionnaire

HLQ

:   Health Literacy Questionnaire

IBD

:   inflammatory bowel disease

ICC

:   intraclass correlation coefficient

QALYs

:   quality-adjusted life years

QoL

:   quality of life

SCCAI

:   Simple Clinical Colitis Activity Index

SDM

:   shared decision making

TPS

:   Trust in Physician Scale

UC

:   ulcerative colitis

WPAI

:   work productivity and activity impairment questionnaire


A 38-year-old female patient with neither diagnosis nor family history of any heart disease was admitted to the regional hospital with sustained ventricular t